Elucidation of the correlation between genotype and clinical behavior in meningeal SFT/HPC
Bijdrage Stichting STOPhersentumoren.nl: 6.987,75- euro uit bestemmingsfonds Meningeomen per 1 november 2015
Determining blood-brain barier penetration of R428, for use in the treatment of diffuse intrinsic pontine glioma (DIPG)
Bijdrage Stichting STOPhersentumoren.nl: 15.100,- euro uit bestemmingsfonds Kinderhersentumoren per 1 november 2015
Polymersomes for local delivery of radionuclides and/or targeted agents to high grade brain tumours
Bijdrage Stichting STOPhersentumoren.nl: 120.987,- euro per 1 november 2015
T-Cell Therapy for Low-Grade Gliomas
Bijdrage Stichting STOPhersentumoren.nl: 90.000,- euro per 1 november 2015
From 'sweet' to treat; elucidating the immune-evasive role of sialic acid sugars and their receptors in malignant glioma'
Bijdrage Stichting STOPhersentumoren.nl: 148.092,- euro per 1 november 2015
Meer artikelen...
- The high grade glioma synergy atlas: Tailored cocktails selected by computational connectivity mapping
- Blood-based diagnosis and monitoring of ‘lower-grade gliomas’ to predict malignant progression and optimize treatment
- Preclinical analysis of a highly promising TMZ sensitizer in molecularly defined glioblastoma subtypes: The novel GPCR inhibitor R243
- Identification of effective compounds targeting IDH-‐1 mutant glioma using novel patient-‐derived preclinical models
